Articles From: Vishay Intertechnology Enhances PTN Series Precision Thin Film Chip Resistors to Twitter wins analyst praise, but not any upgrades


Vishay Intertechnology, Inc. (NYSE: VSH) today announced that it has enhanced its PTN series of precision surface-mount thin film chip resistors with a lower absolute TCR of ± 10 ppm/°C and tighter tolerances to ± 0.05 %. Built using a self-passivated, moisture-resistant tantalum nitride resistive film technology, the Vishay Dale Thin Film devices offer high power ratings to 2 W over a wide temperature range of -55 °C to +155 °C. The tantalum nitride resistive film of the PTN resistor ensures a moisture resistance level that exceeds MIL-PRF-55342 limits.
Sign-up for Vishay Intertechnology Enhances PTN Series Precision Thin Film Chip Resistors investment picks
Shares of Bob Evans Farms (BOBE) tumbled 9.8% in morning trade Wednesday, after KeyBank Capital Markets downgraded them following the full-service restaurant operator's disappointing fiscal second-quarter sales results.
Sign-up for Bob Evans' stock tumbles as sales results prompt analyst downgrade investment picks
2014/11/13
By David Weidner, MarketWatch The financial media pull out the thesaurus to glorify the Wall Street millionaires SAN FRANCISCO (MarketWatch) -- Apologies in advance.
Sign-up for UPDATE: Why Goldman Sachs' partners are better than you investment picks
Visit Intersil at HDcctv Product Gallery to See Long Reach HD Video Demonstration MILPITAS, Calif.
Sign-up for Intersil to Demonstrate HD-SDI Video Transmitter and Receiver ICs for HDcctv Cameras and DVRs at Security China 2014 investment picks
SAN MATEO, Calif.
Sign-up for GoPro Announces Pricing of Follow-on Public Offering investment picks
Supplemental Cash Dividend of $0.275 per Share is in Addition to Regular Monthly Cash Dividends for the Fourth Quarter of 2014 HOUSTON , Oct.
Sign-up for Main Street Announces Preliminary Estimate of Third Quarter 2014 Results and Semi-Annual Supplemental Cash Dividend Payable in December 2014 investment picks
MIDDLETOWN, R.I., Jan.
Sign-up for KVH TracVision A9 Brings Satellite TV Services to Vehicles investment picks
Bristol-Myers Squibb Company (NYSE:BMY) today announced results from CheckMate -066, a Phase 3 randomized double blind study, comparing Opdivo , an investigational PD-1 immune checkpoint inhibitor, to the chemotherapy dacarbazine (DTIC) in patients with treatment naïve BRAF wild-type advanced melanoma (n=418). The study met the primary endpoint of overall survival (OS) with the median OS not reached for Opdivo vs.
Sign-up for Study Comparing Opdivo (nivolumab) to Chemotherapy in Treatment Naïve Advanced Melanoma Patients Marks First PD-1 Immune Checkpoint Inhibitor to Demonstrate a Survival Benefit in a Phase 3 Trial investment picks
2014/10/30
SAN DIEGO , Oct.
Sign-up for General Dynamics NASSCO Receives 2014 Environmental Excellence Award from Industrial Environmental Association investment picks
2015/1/7
Preschoolers will enter a whimsical world of spellbinding adventures when Little Charmers , a brand-new animated preschool series that celebrates the magic of friendship, debuts Monday, Jan.
Sign-up for Little Charmers ‘Turns on the Charm’ on Nickelodeon Monday, Jan. 12, at 12 P.M. (ET/PT) investment picks
2014/12/31
NEW YORK , Dec.
Sign-up for Neuberger Berman MLP Income Fund Announces Monthly Distributions investment picks
2014/12/17
Survey of 21,000 Physicians Reveals Similarities and Differences in Attitudes on Challenging Ethical Issues NEW YORK , Dec.
Sign-up for Medscape Ethics Survey: Life-and-Death Decisions Keeping Doctors Up at Night investment picks
By Barbara Kollmeyer, MarketWatch No heartfelt tweets or blog posts this time, so far From "I'll love you forever ..." to dead silence.
Sign-up for UPDATE: Tesla's Elon Musk and wife Talulah Riley divorce again; tab this time is $16 million investment picks
Universal Electronics Inc. (UEI) (NASDAQ: UEIC) and Peel Technologies, Inc. today announced that they have agreed to dismiss their respective patent infringement claims against each other without prejudice.
Sign-up for Universal Electronics Inc. and Peel Technologies, Inc. Patent Infringement Litigation investment picks
GE Capital’s Franchise Finance (GEFF) business announced today that it has provided financing to Z&H Foods, LLC to develop more than 20 Popeyes units and to refinance debt.
Sign-up for GE Capital Provides Financing to Houston Popeyes Franchisee Z&H Foods investment picks
CYRAMZA now approved both as a single-agent treatment and in combination with chemotherapy INDIANAPOLIS , Nov.
Sign-up for Lilly's CYRAMZA® (ramucirumab) in Combination with Paclitaxel Granted FDA Approval for Advanced Gastric Cancer After Prior Chemotherapy investment picks
-First drug for the underlying cause of nonsense mutation Duchenne muscular dystrophy - SOUTH PLAINFIELD, N.J. , Dec.
Sign-up for PTC Therapeutics Announces Launch of Translarna™ (ataluren) in Germany investment picks
2014/12/10
By Russ Britt, MarketWatch U.S. improves on several fronts, but is getting more obese LOS ANGELES (MarketWatch)--Good health comes at a price and nowhere is that more evident than in a report published Wednesday that says Hawaii--the most expensive state in the union by several measures--is also the healthiest.
Sign-up for Hawaii best, Mississippi worst states for health investment picks
Merck (NYSE:MRK), known as MSD outside the United States and Canada, and NewLink Genetics Corporation (NASDAQ:NLNK), announced today that they have entered into an exclusive worldwide license agreement to research, develop, manufacture, and distribute NewLink’s investigational rVSV-EBOV (Ebola) vaccine candidate.
Sign-up for Merck and NewLink Genetics Enter Into Licensing and Collaboration Agreement for Investigational Ebola Vaccine investment picks
HOUSTON , Nov.
Sign-up for Salient Midstream & MLP Fund Announces Fourth Quarter 2014 Dividend investment picks
2014/10/30
BASILDON, United Kingdom, Oct.
Sign-up for CNH Industrial Third Quarter Revenues Of $7.7 Billion, Net Income Of $162 Million investment picks
- Expects Adjusted Earnings Per Share of $4.25 to $4.45 (GAAP EPS of $3.99 to $4.19); Guidance to be Further Refined as HCV Launch Progresses - Guidance Midpoint Reflects Adjusted EPS Growth of More Than 30 Percent from AbbVie's Previously Communicated 2014 Guidance Range NORTH CHICAGO, Ill.
Sign-up for AbbVie Issues Strong Outlook for 2015 investment picks
Pfizer Inc. (NYSE:PFE) announced today the publication of results from the PROFILE 1014 study in the December 4 issue of The New England Journal of Medicine .
Sign-up for Phase 3 Results Published in The New England Journal of Medicine Show Superiority of Pfizer’s XALKORI® (crizotinib) Compared to Platinum-Based Chemotherapy in Previously Untreated Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer investment picks
NEW YORK and DHAKA, Bangladesh, Dec.
Sign-up for Dhaka Stock Exchange Goes Live With New Trading Engine Powered by Nasdaq investment picks
By Jennifer Booton, MarketWatch Twitter pressured to execute after delivering lofty promises NEW YORK (MarketWatch) -- While analysts were optimistic on Twitter after its eight-hour analyst day this week, no major brokerages have raised their ratings or price targets on the stock as of Thursday morning.
Sign-up for Twitter wins analyst praise, but not any upgrades investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Vishay Intertechnology Enhances PTN Series Precision Thin Film Chip Resistors to Twitter wins analyst praise, but not any upgrades
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent